Logo image of 1RCAT.MI

RED CAT HOLDINGS INC (1RCAT.MI) Stock Fundamental Analysis

BIT:1RCAT - Euronext Milan - US75644T1007 - Common Stock - Currency: EUR

8.8  +8.8 (+Infinity%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1RCAT. 1RCAT was compared to 52 industry peers in the Electronic Equipment, Instruments & Components industry. 1RCAT may be in some trouble as it scores bad on both profitability and health. 1RCAT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

1RCAT had negative earnings in the past year.
In the past year 1RCAT has reported a negative cash flow from operations.
1RCAT had negative earnings in each of the past 5 years.
1RCAT had a negative operating cash flow in each of the past 5 years.
1RCAT.MI Yearly Net Income VS EBIT VS OCF VS FCF1RCAT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

1RCAT has a Return On Assets of -111.87%. This is amonst the worse of the industry: 1RCAT underperforms 90.38% of its industry peers.
1RCAT's Return On Equity of -230.83% is on the low side compared to the rest of the industry. 1RCAT is outperformed by 88.46% of its industry peers.
Industry RankSector Rank
ROA -111.87%
ROE -230.83%
ROIC N/A
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
1RCAT.MI Yearly ROA, ROE, ROIC1RCAT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for 1RCAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1RCAT.MI Yearly Profit, Operating, Gross Margins1RCAT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

3

2. Health

2.1 Basic Checks

1RCAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
1RCAT has more shares outstanding than it did 1 year ago.
The debt/assets ratio for 1RCAT has been reduced compared to a year ago.
1RCAT.MI Yearly Shares Outstanding1RCAT.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2020 2021 2022 2023 2024 20M 40M 60M
1RCAT.MI Yearly Total Debt VS Total Assets1RCAT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

1RCAT has an Altman-Z score of 14.31. This indicates that 1RCAT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of 1RCAT (14.31) is better than 98.08% of its industry peers.
A Debt/Equity ratio of 0.87 indicates that 1RCAT is somewhat dependend on debt financing.
The Debt to Equity ratio of 1RCAT (0.87) is worse than 71.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF N/A
Altman-Z 14.31
ROIC/WACCN/A
WACC9.54%
1RCAT.MI Yearly LT Debt VS Equity VS FCF1RCAT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

1RCAT has a Current Ratio of 1.02. This is a normal value and indicates that 1RCAT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, 1RCAT is not doing good in the industry: 82.69% of the companies in the same industry are doing better.
1RCAT has a Quick Ratio of 1.02. This is a bad value and indicates that 1RCAT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.43, 1RCAT is not doing good in the industry: 88.46% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.43
1RCAT.MI Yearly Current Assets VS Current Liabilites1RCAT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for 1RCAT have decreased by -3.70% in the last year.
Looking at the last year, 1RCAT shows a very strong growth in Revenue. The Revenue has grown by 79.98%.
1RCAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.80% yearly.
EPS 1Y (TTM)-3.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.45%
Revenue 1Y (TTM)79.98%
Revenue growth 3Y52.8%
Revenue growth 5YN/A
Sales Q2Q%-72.13%

3.2 Future

Based on estimates for the next years, 1RCAT will show a very strong growth in Earnings Per Share. The EPS will grow by 39.49% on average per year.
Based on estimates for the next years, 1RCAT will show a very strong growth in Revenue. The Revenue will grow by 123.37% on average per year.
EPS Next Y-2%
EPS Next 2Y49.03%
EPS Next 3Y39.49%
EPS Next 5YN/A
Revenue Next Year341.59%
Revenue Next 2Y188.86%
Revenue Next 3Y123.37%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1RCAT.MI Yearly Revenue VS Estimates1RCAT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
1RCAT.MI Yearly EPS VS Estimates1RCAT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 1RCAT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 116.46 indicates a quite expensive valuation of 1RCAT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1RCAT indicates a slightly more expensive valuation: 1RCAT is more expensive than 65.38% of the companies listed in the same industry.
1RCAT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 37.36.
Industry RankSector Rank
PE N/A
Fwd PE 116.46
1RCAT.MI Price Earnings VS Forward Price Earnings1RCAT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1RCAT.MI Per share data1RCAT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as 1RCAT's earnings are expected to grow with 39.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.03%
EPS Next 3Y39.49%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1RCAT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RED CAT HOLDINGS INC

BIT:1RCAT (7/15/2025, 7:00:00 PM)

8.8

+8.8 (+Infinity%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners19.83%
Inst Owner ChangeN/A
Ins Owners14.89%
Ins Owner ChangeN/A
Market Cap866.10M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-114.29%
Min EPS beat(2)-152.1%
Max EPS beat(2)-76.47%
EPS beat(4)0
Avg EPS beat(4)-103.43%
Min EPS beat(4)-152.1%
Max EPS beat(4)-40.06%
EPS beat(8)1
Avg EPS beat(8)-107.24%
EPS beat(12)2
Avg EPS beat(12)-142.52%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-62.74%
Min Revenue beat(2)-92.04%
Max Revenue beat(2)-33.43%
Revenue beat(4)0
Avg Revenue beat(4)-52.2%
Min Revenue beat(4)-92.04%
Max Revenue beat(4)-9.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 116.46
P/S 156.37
P/FCF N/A
P/OCF N/A
P/B 35.05
P/tB 317.35
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)0.08
Fwd EY0.86%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.06
BVpS0.25
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -111.87%
ROE -230.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.41%
Cap/Sales 3.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.43
Altman-Z 14.31
F-Score3
WACC9.54%
ROIC/WACCN/A
Cap/Depr(3y)137.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.45%
EPS Next Y-2%
EPS Next 2Y49.03%
EPS Next 3Y39.49%
EPS Next 5YN/A
Revenue 1Y (TTM)79.98%
Revenue growth 3Y52.8%
Revenue growth 5YN/A
Sales Q2Q%-72.13%
Revenue Next Year341.59%
Revenue Next 2Y188.86%
Revenue Next 3Y123.37%
Revenue Next 5YN/A
EBIT growth 1Y22.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.73%
EBIT Next 3Y56.58%
EBIT Next 5YN/A
FCF growth 1Y40.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.43%
OCF growth 3YN/A
OCF growth 5YN/A